220 related articles for article (PubMed ID: 27595738)
1. Three residues in the luminal domain of triadin impact on Trisk 95 activation of skeletal muscle ryanodine receptors.
Wium E; Dulhunty AF; Beard NA
Pflugers Arch; 2016 Nov; 468(11-12):1985-1994. PubMed ID: 27595738
[TBL] [Abstract][Full Text] [Related]
2. Triadin binding to the C-terminal luminal loop of the ryanodine receptor is important for skeletal muscle excitation contraction coupling.
Goonasekera SA; Beard NA; Groom L; Kimura T; Lyfenko AD; Rosenfeld A; Marty I; Dulhunty AF; Dirksen RT
J Gen Physiol; 2007 Oct; 130(4):365-78. PubMed ID: 17846166
[TBL] [Abstract][Full Text] [Related]
3. A skeletal muscle ryanodine receptor interaction domain in triadin.
Wium E; Dulhunty AF; Beard NA
PLoS One; 2012; 7(8):e43817. PubMed ID: 22937102
[TBL] [Abstract][Full Text] [Related]
4. The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium.
Györke I; Hester N; Jones LR; Györke S
Biophys J; 2004 Apr; 86(4):2121-8. PubMed ID: 15041652
[TBL] [Abstract][Full Text] [Related]
5. Junctin and triadin each activate skeletal ryanodine receptors but junctin alone mediates functional interactions with calsequestrin.
Wei L; Gallant EM; Dulhunty AF; Beard NA
Int J Biochem Cell Biol; 2009 Nov; 41(11):2214-24. PubMed ID: 19398037
[TBL] [Abstract][Full Text] [Related]
6. Negatively charged amino acids within the intraluminal loop of ryanodine receptor are involved in the interaction with triadin.
Lee JM; Rho SH; Shin DW; Cho C; Park WJ; Eom SH; Ma J; Kim DH
J Biol Chem; 2004 Feb; 279(8):6994-7000. PubMed ID: 14638677
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of atypical Ca2+ transients in triadin-binding deficient-RYR1 mutants.
Lee EH; Song DW; Lee JM; Meissner G; Allen PD; Kim DH
Biochem Biophys Res Commun; 2006 Dec; 351(4):909-14. PubMed ID: 17092484
[TBL] [Abstract][Full Text] [Related]
8. Caveolin 3 is associated with the calcium release complex and is modified via in vivo triadin modification.
Vassilopoulos S; Oddoux S; Groh S; Cacheux M; Fauré J; Brocard J; Campbell KP; Marty I
Biochemistry; 2010 Jul; 49(29):6130-5. PubMed ID: 20565104
[TBL] [Abstract][Full Text] [Related]
9. Calsequestrin and the calcium release channel of skeletal and cardiac muscle.
Beard NA; Laver DR; Dulhunty AF
Prog Biophys Mol Biol; 2004 May; 85(1):33-69. PubMed ID: 15050380
[TBL] [Abstract][Full Text] [Related]
10. Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane.
Zhang L; Kelley J; Schmeisser G; Kobayashi YM; Jones LR
J Biol Chem; 1997 Sep; 272(37):23389-97. PubMed ID: 9287354
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of skeletal muscle calsequestrin enhances its Ca2+ binding capacity and promotes its association with junctin.
Beard NA; Wei L; Cheung SN; Kimura T; Varsányi M; Dulhunty AF
Cell Calcium; 2008 Oct; 44(4):363-73. PubMed ID: 19230141
[TBL] [Abstract][Full Text] [Related]
12. Control of muscle ryanodine receptor calcium release channels by proteins in the sarcoplasmic reticulum lumen.
Beard NA; Wei L; Dulhunty AF
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):340-5. PubMed ID: 19278523
[TBL] [Abstract][Full Text] [Related]
13. The asp-rich region at the carboxyl-terminus of calsequestrin binds to Ca(2+) and interacts with triadin.
Shin DW; Ma J; Kim DH
FEBS Lett; 2000 Dec; 486(2):178-82. PubMed ID: 11113462
[TBL] [Abstract][Full Text] [Related]
14. Ablation of skeletal muscle triadin impairs FKBP12/RyR1 channel interactions essential for maintaining resting cytoplasmic Ca2+.
Eltit JM; Feng W; Lopez JR; Padilla IT; Pessah IN; Molinski TF; Fruen BR; Allen PD; Perez CF
J Biol Chem; 2010 Dec; 285(49):38453-62. PubMed ID: 20926377
[TBL] [Abstract][Full Text] [Related]
15. C-terminal residues of skeletal muscle calsequestrin are essential for calcium binding and for skeletal ryanodine receptor inhibition.
Beard NA; Dulhunty AF
Skelet Muscle; 2015; 5():6. PubMed ID: 25861445
[TBL] [Abstract][Full Text] [Related]
16. Altered stored calcium release in skeletal myotubes deficient of triadin and junctin.
Wang Y; Li X; Duan H; Fulton TR; Eu JP; Meissner G
Cell Calcium; 2009 Jan; 45(1):29-37. PubMed ID: 18620751
[TBL] [Abstract][Full Text] [Related]
17. Triadin (Trisk 95) overexpression blocks excitation-contraction coupling in rat skeletal myotubes.
Rezgui SS; Vassilopoulos S; Brocard J; Platel JC; Bouron A; Arnoult C; Oddoux S; Garcia L; De Waard M; Marty I
J Biol Chem; 2005 Nov; 280(47):39302-8. PubMed ID: 16176928
[TBL] [Abstract][Full Text] [Related]
18. The cytoplasmic loops between domains II and III and domains III and IV in the skeletal muscle dihydropyridine receptor bind to a contiguous site in the skeletal muscle ryanodine receptor.
Leong P; MacLennan DH
J Biol Chem; 1998 Nov; 273(45):29958-64. PubMed ID: 9792715
[TBL] [Abstract][Full Text] [Related]
19. Molecular interaction between ryanodine receptor and glycoprotein triadin involves redox cycling of functionally important hyperreactive sulfhydryls.
Liu G; Pessah IN
J Biol Chem; 1994 Dec; 269(52):33028-34. PubMed ID: 7806531
[TBL] [Abstract][Full Text] [Related]
20. Human skeletal muscle triadin: gene organization and cloning of the major isoform, Trisk 51.
Thevenon D; Smida-Rezgui S; Chevessier F; Groh S; Henry-Berger J; Beatriz Romero N; Villaz M; DeWaard M; Marty I
Biochem Biophys Res Commun; 2003 Apr; 303(2):669-75. PubMed ID: 12659871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
